Asalyxa Bio Revenue and Competitors
Estimated Revenue & Valuation
- Asalyxa Bio's estimated annual revenue is currently $387.5k per year.
- Asalyxa Bio's estimated revenue per employee is $77,500
- Asalyxa Bio's total funding is $2M.
Employee Data
- Asalyxa Bio has 5 Employees.
- Asalyxa Bio grew their employee count by -17% last year.
Asalyxa Bio's People
| Name | Title | Email/Phone |
|---|
Asalyxa Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.9M | 12 | 0% | N/A | N/A |
#2 | $2.6M | 34 | -56% | $31.2M | N/A |
#3 | $0.8M | 5 | -44% | N/A | N/A |
#4 | $1.9M | 24 | 100% | N/A | N/A |
#5 | $6M | 39 | -11% | N/A | N/A |
#6 | $4M | 26 | -33% | N/A | N/A |
#7 | $1.9M | 12 | 0% | N/A | N/A |
#8 | $0.8M | 5 | 25% | N/A | N/A |
#9 | $14.6M | 94 | 8% | N/A | N/A |
#10 | $3.4M | 22 | 5% | N/A | N/A |
What Is Asalyxa Bio?
Asalyxa is focused on the rapid development of a revolutionary neutrophil-targeting drug platform. The versatility of Asalyxa's proprietary platform allows for the direct delivery of microparticles into neutrophils, making the platform ideal for a variety of diseases where treatments are limited or do not exist. Asalyxa is committed to developing neutrophil targeting treatments for diseases with a high unmet medical need, allowing today's patients to enjoy a healthier tomorrow.
keywords:N/A
$2M
Total Funding
5
Number of Employees
$387.5k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Asalyxa Bio News
Asalyxa Bio, Inc., an Ann Arbor, Mich.-based biopharmaceutical company developing nano-engineered, immune cell-targeted therapeutics, closed a seed financing round totaling more than $2m. The round was led by Research Bridge Partners, co-led by ID Ventures, and also included Michigan Rise Pre-S ...
Other Companies in Southfield
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 5 | -29% | N/A |
#2 | $0.4M | 5 | 0% | N/A |
#3 | $0.4M | 5 | 0% | N/A |
#4 | $0.4M | 6 | 0% | N/A |
#5 | $0.4M | 6 | 20% | N/A |